Developing new treatments for trauma care
Engineering Technologies for Acute Trauma Care
['FUNDING_R01'] · UNIVERSITY OF WASHINGTON · NIH-11130857
This study is working on new ways to help people who have serious injuries from accidents or violence by creating special fluids that can keep them stable during the crucial first hour after their injury, making sure they have better chances of recovery before they even get to the hospital.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11130857 on ClinicalTrials.gov |
What this research studies
This research focuses on improving care for trauma patients, particularly those suffering from severe injuries due to accidents or violence. It aims to create innovative synthetic therapies that can stabilize patients during the critical first hour after injury, known as the 'golden hour.' The approach involves developing low-volume resuscitation fluids that help maintain blood clotting and immune function while reducing inflammation. By addressing the limitations of current treatments, this research seeks to enhance outcomes for trauma victims before they reach the hospital.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced acute trauma from accidents or violence.
Not a fit: Patients with chronic conditions unrelated to acute trauma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new life-saving treatments for trauma patients that improve survival rates and recovery times.
How similar studies have performed: Previous research has shown promise in developing synthetic resuscitation fluids, indicating potential for success in this novel approach.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PUN, SUZIE H. — UNIVERSITY OF WASHINGTON
- Study coordinator: PUN, SUZIE H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome